Skip to main content
. 2016 Apr 18;8(4):45. doi: 10.3390/cancers8040045
3BP 3-bromopyruvate
BPTES bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide
CDK cyclin-dependent kinase
CDKN2A cyclin-dependent kinase inhibitor 2A
CTLA-4 cytotoxic T lymphocyte antigen-4
DOPC 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine
EAA essential amino acid
EIPA 5-(N-ethyl-N-isopropyl)amiloride
ER Endoplasmic Reticulum
FBLD fragment-based lead discovery
FTase farnesyltransferase
FTI farnesyl transferase inhibitor
FTS farnesyl thiosalicylic acid
GAP GTPase activating proteins
GDP guanosine diphosphate
GEF guanine nucleotide exchange factors
GTP guanosine triphosphate
HA hyaluronic acid
HBS hydrogen bond surrogate
HCQ hydroxychloroquine
Hk1 hexokinase 1
Hk2 hexokinase 2
ICMT isoprenylcysteine methyltransferase
LDHA lactate dehydrogenase A
LODER Local Drug EluteR
MHC major histocompatibility complexes
mTOR mammalian target of rapamycin
mTORC1 mTOR complex 1
mTORC2 mTOR complex 2
NSCLC Non-small cell lung cancer
PanIN pancreatic intraepithelial neoplasia
PDAC Pancreatic Ductal Adenocarcinoma
PDEδ Phosphodiesterase δ
Pfk1 phosphofructokinase
PFS progression free survival
PH pleckstrin homology
PIP2 phosphatidylinositol 4,5-bisphosphate
PKC protein kinase C
PPP pentose phosphate pathway
RCE1 RAS converting enzyme 1
RNAi RNA interference
Serine 181 S181
SOS Son of Sevenless
TP53 tumor protein 53